Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Neale Weitzmann

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 2014
T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatmentJerid W Robinson, Jau-Yi Li, Lindsey D Walker, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 5, 2020
Plasma high-resolution metabolomics identifies linoleic acid and linked metabolic pathways associated with bone mineral densityMoriah P Bellissimo, Thomas R Ziegler, Dean P Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTHBrahmchetna Bedi, Jau-Yi Li, Hesham Tawfeek, et al.
The Journal of Clinical Investigation|March 26, 2024
Gender-affirming hormone therapy preserves skeletal maturation in young mice via the gut microbiomeSubhashis Pal, Xochitl Morgan, Hamid Y Dar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2005
An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiencyMichaela Robbie Ryan, Rebecca Shepherd, Jennifer K Leavey, et al.
EMBO Reports|November 22, 2017
Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in miceMingcan Yu, Patrizia D'Amelio, Abdul Malik Tyagi, et al.
AIDS (London, England)|January 14, 2016
Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infectionIghovwerha Ofotokun, Kehmia Titanji, Aswani Vunnava, et al.
Plos Pathogens|November 14, 2014
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infectionKehmia Titanji, Aswani Vunnava, Anandi N Sheth, et al.
Immunity|November 18, 2018
The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B ExpressionAbdul Malik Tyagi, Mingcan Yu, Trevor M Darby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Antiretroviral Therapy-Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB TrialIghovwerha Ofotokun, Lauren F Collins, Kehmia Titanji, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 1, 2014
T cell-expressed CD40L potentiates the bone anabolic activity of intermittent PTH treatmentJerid W Robinson, Jau-Yi Li, Lindsey D Walker, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 5, 2020
Plasma high-resolution metabolomics identifies linoleic acid and linked metabolic pathways associated with bone mineral densityMoriah P Bellissimo, Thomas R Ziegler, Dean P Jones, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 7, 2012
Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTHBrahmchetna Bedi, Jau-Yi Li, Hesham Tawfeek, et al.
The Journal of Clinical Investigation|March 26, 2024
Gender-affirming hormone therapy preserves skeletal maturation in young mice via the gut microbiomeSubhashis Pal, Xochitl Morgan, Hamid Y Dar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2005
An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiencyMichaela Robbie Ryan, Rebecca Shepherd, Jennifer K Leavey, et al.
EMBO Reports|November 22, 2017
Regulatory T cells are expanded by Teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in miceMingcan Yu, Patrizia D'Amelio, Abdul Malik Tyagi, et al.
AIDS (London, England)|January 14, 2016
Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infectionIghovwerha Ofotokun, Kehmia Titanji, Aswani Vunnava, et al.
Plos Pathogens|November 14, 2014
Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infectionKehmia Titanji, Aswani Vunnava, Anandi N Sheth, et al.
Immunity|November 18, 2018
The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B ExpressionAbdul Malik Tyagi, Mingcan Yu, Trevor M Darby, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2019
Antiretroviral Therapy-Induced Bone Loss Is Durably Suppressed by a Single Dose of Zoledronic Acid in Treatment-Naive Persons with Human Immunodeficiency Virus Infection: A Phase IIB TrialIghovwerha Ofotokun, Lauren F Collins, Kehmia Titanji, et al.
Pageof 12